Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.

Literature DB >> 15793168

Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.

James S Lewis, Aaron Owens, Jose Cadena, Kathryn Sabol, Jan E Patterson, James H Jorgensen.

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 2005 PMID： 15793168 PMCID： PMC1068653 DOI： 10.1128/AAC.49.4.1664-1665.2005

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

× No keyword cloud information.

6 in total

1. Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin.

Authors: Issam I Raad; Hend A Hanna; Ray Y Hachem; Tanya Dvorak; Rebecca B Arbuckle; Gassan Chaiban; Louis B Rice
Journal: Antimicrob Agents Chemother Date: 2004-09 Impact factor: 5.191

2. Linezolid resistance in a clinical isolate of Staphylococcus aureus.

Authors: S Tsiodras; H S Gold; G Sakoulas; G M Eliopoulos; C Wennersten; L Venkataraman; R C Moellering; M J Ferraro
Journal: Lancet Date: 2001-07-21 Impact factor: 79.321

3. Daptomycin against multiple drug-resistant staphylococcus and enterococcus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations.

Authors: Raymond Cha; Michael J Rybak
Journal: Diagn Microbiol Infect Dis Date: 2003-11 Impact factor: 2.803

4. In vitro activity of daptomycin against vancomycin-resistant enterococci of various Van types and comparison of susceptibility testing methods.

Authors: James H Jorgensen; Sharon A Crawford; Cynthia C Kelly; Jan E Patterson
Journal: Antimicrob Agents Chemother Date: 2003-12 Impact factor: 5.191

5. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections.

Authors: Robert D Arbeit; Dennis Maki; Francis P Tally; Edward Campanaro; Barry I Eisenstein
Journal: Clin Infect Dis Date: 2004-05-20 Impact factor: 9.079

6. Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid.

Authors: Sibtain Rahim; Satish K Pillai; Howard S Gold; Lata Venkataraman; Kenneth Inglima; Robert A Press
Journal: Clin Infect Dis Date: 2003-05-20 Impact factor: 9.079

6 in total

64 in total

1. Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints.

Authors: Jose M Munita; Diana Panesso; Lorena Diaz; Truc T Tran; Jinnethe Reyes; Audrey Wanger; Barbara E Murray; Cesar A Arias
Journal: Antimicrob Agents Chemother Date: 2012-06-04 Impact factor: 5.191

2. Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in an In Vitro Pharmacokinetic-Pharmacodynamic Model.

Authors: Ashley D Hall Snyder; Brian J Werth; Poochit Nonejuie; John P McRoberts; Joe Pogliano; George Sakoulas; Juwon Yim; Nivedita Singh; Michael J Rybak
Journal: Antimicrob Agents Chemother Date: 2016-09-23 Impact factor: 5.191

3. Assessment of two commercial susceptibility test methods for determination of daptomycin MICs.

Authors: James H Jorgensen; Sharon A Crawford
Journal: J Clin Microbiol Date: 2006-06 Impact factor: 5.948

Review 4. Antimicrobial agents for treatment of serious infections caused by resistant Staphylococcus aureus and enterococci.

Authors: G M Eliopoulos
Journal: Eur J Clin Microbiol Infect Dis Date: 2005-12 Impact factor: 3.267

5. De novo daptomycin nonsusceptibility in a clinical isolate.

Authors: Emil P Lesho; Glenn W Wortmann; David Craft; Kimberly A Moran
Journal: J Clin Microbiol Date: 2006-02 Impact factor: 5.948

6. Enterococci: on the back burner but still simmering.

Authors: George M Eliopoulos
Journal: Curr Infect Dis Rep Date: 2006-09 Impact factor: 3.725

7. Disrupting Membrane Adaptation Restores In Vivo Efficacy of Antibiotics Against Multidrug-Resistant Enterococci and Potentiates Killing by Human Neutrophils.

Authors: Sandra Rincon; Diana Panesso; William R Miller; Kavindra V Singh; Melissa R Cruz; Ayesha Khan; An Q Dinh; Lorena Diaz; Rafael Rios; Yousif Shamoo; Jinnethe Reyes; Truc T Tran; Danielle A Garsin; Cesar A Arias
Journal: J Infect Dis Date: 2019-07-02 Impact factor: 5.226